ProCE Banner Activity

ExpressPoints
Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum

Slideset Download
Download this short summary slideset of takeaway points from a live presentation on current clinical guidance and key data on the optimal use of androgen deprivation therapy for nonmetastatic or metastatic prostate cancer.

Released: September 20, 2021

Expiration: September 19, 2022

No longer available for credit.

Share

Faculty

Daniel W. Lin

Daniel W. Lin, MD

Professor and Chief of Urologic Oncology
Department of Urology
University of Washington
Seattle, Washington

Alicia K. Morgans

Alicia K. Morgans, MD, MPH

Genitourinary Medical Oncologist
Dana-Farber Cancer Institute
Boston, Massachusetts

David F. Penson

David F. Penson, MD, MPH

Professor and Chair
Department of Urology
Vanderbilt University School of Medicine
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Astellas Text

Bayer Healthcare Pharma

Myovant Sciences Ltd

Pfizer, Inc.

Faculty Disclosure

Primary Author

Daniel W. Lin, MD

Professor and Chief of Urologic Oncology
Department of Urology
University of Washington
Seattle, Washington

Daniel W. Lin, MD

Alicia K. Morgans, MD, MPH

Genitourinary Medical Oncologist
Dana-Farber Cancer Institute
Boston, Massachusetts

Alicia K. Morgans, MD, MPH

David F. Penson, MD, MPH

Professor and Chair
Department of Urology
Vanderbilt University School of Medicine
Nashville, Tennessee

David F. Penson, MD